{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:20:51Z","timestamp":1763619651846},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,9,6]],"date-time":"2006-09-06T00:00:00Z","timestamp":1157500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1748-717x-1-35","type":"journal-article","created":{"date-parts":[[2006,9,6]],"date-time":"2006-09-06T18:20:24Z","timestamp":1157566824000},"source":"Crossref","is-referenced-by-count":8,"title":["Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation"],"prefix":"10.1186","volume":"1","author":[{"given":"Andrea Riccardo","family":"Filippi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfrancesco","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Galliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,6]]},"reference":[{"key":"35_CR1","first-page":"115","volume":"36","author":"E Campo","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES: Mantle-Cell Lymphoma. Semin Hemat 1999, 36: 115-127.","journal-title":"Semin Hemat"},{"key":"35_CR2","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1200\/JCO.2005.55.017","volume":"23","author":"TE Witzig","year":"2005","unstructured":"Witzig TE: Current treatment approaches for Mantle-Cell Lymphoma. J Clin Oncol 2005, 23: 6409-6414. 10.1200\/JCO.2005.55.017","journal-title":"J Clin Oncol"},{"key":"35_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0959-8049(01)00366-5","volume":"38","author":"NS Andersen","year":"2002","unstructured":"Andersen NS, Jensen MK, de Nully Brown P, Geisler CH: A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. Eur J Cancer 2002, 38: 401-408. 10.1016\/S0959-8049(01)00366-5","journal-title":"Eur J Cancer"},{"key":"35_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1309\/R2BC-2H7T-7KB6-0YG8","volume":"117","author":"PE Peghini","year":"2002","unstructured":"Peghini PE, Fehr J: Analysis of Cyclin D1 expression by Quantitative Real-Time Reverse Transcription-Polymerase Chain Reaction in the diagnosis of Mantle Cell Lymphoma. Am J Clin Pathol 2002, 117: 237-245. 10.1309\/R2BC-2H7T-7KB6-0YG8","journal-title":"Am J Clin Pathol"},{"key":"35_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0167-8140(00)00316-9","volume":"58","author":"M Weinmann","year":"2001","unstructured":"Weinmann M, Becker G, Einsele H, Bamberg M: Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother Oncol 2001, 58: 235-246. 10.1016\/S0167-8140(00)00316-9","journal-title":"Radiother Oncol"},{"key":"35_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/1097-0142(19860915)58:6<1204::AID-CNCR2820580605>3.0.CO;2-G","volume":"58","author":"H Wagner Jr.","year":"1986","unstructured":"Wagner H Jr, McKeough PG, Desforges J, Madoc-Jones H: Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea. Cancer 1986, 58: 1204-1207. Publisher Full Text 10.1002\/1097-0142(19860915)58:6<1204::AID-CNCR2820580605>3.0.CO;2-G","journal-title":"Cancer"},{"key":"35_CR7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/030089168206800610","volume":"68","author":"G De Rossi","year":"1982","unstructured":"De Rossi G, Biagnini C, Lopez M, Tombolini V, Mandelli F: Treatment by splenic irradiation in 22 chronic lymphocytic leukemia patients. Tumori 1982, 68: 511-514.","journal-title":"Tumori"},{"key":"35_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1054\/blre.1999.0110","volume":"13","author":"MA Elliott","year":"1999","unstructured":"Elliott MA, Tefferi A: Splenic irradiation in myelofibrosis with myeloid metaplasia: a review. Blood Rev 1999, 13: 163-170. 10.1054\/blre.1999.0110","journal-title":"Blood Rev"},{"key":"35_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/00000421-200304000-00016","volume":"26","author":"JT McFarland","year":"2003","unstructured":"McFarland JT, Kuzma C, Millard FE, Johnstone PA: Palliative irradiation of the spleen. Am J Clin Oncol 2003, 26: 178-183. 10.1097\/00000421-200304000-00016","journal-title":"Am J Clin Oncol"},{"key":"35_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1365-2141.1990.tb07889.x","volume":"76","author":"J Muncunill","year":"1990","unstructured":"Muncunill J, Villa S, Domingo A, Domenech P, Arnaiz MD, Callis M: Splenic irradiation as primary therapy for prolymphocytic leukemia. Br J Hematol 1990, 76: 305-306.","journal-title":"Br J Hematol"},{"key":"35_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000206690","volume":"70","author":"RA Sharp","year":"1983","unstructured":"Sharp RA, MacWalter RS: A role for splenic irradiation in the treatment of hairy-cell leukaemia. Case report and review of the literature. Acta Haematol 1983, 70: 59-62.","journal-title":"Acta Haematol"},{"key":"35_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/09553008514552081","volume":"48","author":"AE Thomson","year":"1985","unstructured":"Thomson AE, Vaughan-Smith S, Peel WE, Wetherley-Mein G: The intrinsic radiosensitivity of lymphocytes in chronic lymphocytic leukaemia, quantitatively determined independently of cell death rate factors. Int J Radiat Biol Relat Stud Phys Chem Med 1985, 48: 943-961.","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"35_CR13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/10428199709051790","volume":"26","author":"D Sgarabotto","year":"1997","unstructured":"Sgarabotto D, Vianello F, Radossi P, Poletti A, Sotti G, Stefani PM, Sartori R, Girolami A: Remission in hairy-cell leukaemia-variant following splenic radiotherapy alone. Leuk Lymphoma 1997, 26: 395-398.","journal-title":"Leuk Lymphoma"},{"key":"35_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1600-0609.1991.tb00541.x","volume":"46","author":"T Chisesi","year":"1991","unstructured":"Chisesi T, Capnist G, Dal Fior S: Splenic irradiation in chronic lymphocytic leukaemia. Eur J Hematol 1991, 46: 202-204.","journal-title":"Eur J Hematol"},{"key":"35_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/ajh.2830300313","volume":"30","author":"A Kiss","year":"1989","unstructured":"Kiss A, Haubenstock A, Bognar H, Scheiderbauer R, al-Mobarak M, Base W: Splenic irradiation as primary therapy for prolymphocytic leukaemia. Am J Hematol 1989, 30: 188-189.","journal-title":"Am J Hematol"},{"key":"35_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1259\/0007-1285-68-813-997","volume":"68","author":"J Delic","year":"1995","unstructured":"Delic J, Magdelenat H, Barbaroux C, Chaillet MP, Dubray B, Gluckman E, Fourquet A, Girinsky T, Cosset JM: In-vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. Br J Radiol 1995, 68: 997-1003.","journal-title":"Br J Radiol"},{"key":"35_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-8140(85)80061-X","volume":"4","author":"B Paule","year":"1985","unstructured":"Paule B, Cosset JM, Le Bourgeois JP: The possible role of splenic irradiation in chronic lymphocytic leukaemia: a critical review. Radiother Oncol 1985, 4: 45-54.","journal-title":"Radiother Oncol"},{"key":"35_CR18","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/0959-8049(92)90079-H","volume":"28A","author":"D De Ruysscher","year":"1992","unstructured":"De Ruysscher D, Waer M, Vandeputte M, Aerts R, Vantongelen K, van der Schueren E: Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis : Long term increase of activated (HLA-DR +) T cells and decrease of 'naive' (CD4\/CD45R) T lymphocytes. Eur J Cancer 1992, 28A: 1729-1734. 10.1016\/0959-8049(92)90079-H","journal-title":"Eur J Cancer"},{"key":"35_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ajh.2830460202","volume":"46","author":"H Bessler","year":"1994","unstructured":"Bessler H, Notti I, Cohen AM, Klein B, Djaldetti M: Inhibition of leukemic cell proliferation by factor (s) released from irradiated lymphocytes of B-chronic lymphocytic leukaemia patients. Am J Hematol 1994, 46: 65-71.","journal-title":"Am J Hematol"},{"key":"35_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mrfmmm.2005.12.001","volume":"597","author":"JB Little","year":"2006","unstructured":"Little JB: Cellular radiation effects and the bystander response. Mut Res 2006, 597: 113-118.","journal-title":"Mut Res"},{"key":"35_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ctrv.2005.03.004","volume":"31","author":"JM Kaminski","year":"2005","unstructured":"Kaminski JM, Shinohara E, Summers JB, Niermann KJ, Morimoto A, Brousal J: The controversial abscopal effect. Cancer Treat Rev 2005, 31: 159-172. 10.1016\/j.ctrv.2005.03.004","journal-title":"Cancer Treat Rev"},{"key":"35_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1470-2045(05)70246-1","volume":"6","author":"KM Prise","year":"2005","unstructured":"Prise KM, Schettino G, Folkard M, Held KD: New insights on cell death from radiation exposure. Lancet Oncol 2005, 6: 520-528. 10.1016\/S1470-2045(05)70246-1","journal-title":"Lancet Oncol"},{"key":"35_CR23","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1073\/pnas.050400997","volume":"97","author":"C Schaffner","year":"2000","unstructured":"Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P: Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Nat Acad Sci USA 2000, 97: 2773-2778. 10.1073\/pnas.050400997","journal-title":"Proc Nat Acad Sci USA"},{"key":"35_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.V99.1.238","volume":"99","author":"E Camacho","year":"2002","unstructured":"Camacho E, Hernandez L, Hernandez S, Tort F, Bellosillo B, Bea S, Bosch F, Montserrat E, Cardesa A, Fernandez PL, Campo E: ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 2002, 99: 238-44. 10.1182\/blood.V99.1.238","journal-title":"Blood"},{"key":"35_CR25","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1073\/pnas.0831102100","volume":"100","author":"NY Fang","year":"2003","unstructured":"Fang NY, Greiner TC, Weisenburger DD, Chan WC, Vose JM, Smith LM, Armitage JO, Mayer RA, Pike BL, Collins FS, Hacia JG: Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc Nat Acad Sci USA 2003, 100: 5372-5377. 10.1073\/pnas.0831102100","journal-title":"Proc Nat Acad Sci USA"},{"key":"35_CR26","doi-asserted-by":"publisher","first-page":"7905","DOI":"10.1038\/sj.onc.1206826","volume":"22","author":"R M'kacher","year":"2003","unstructured":"M'kacher R, Bennaceur A, Farace F, Lauge A, Plassa LF, Wittmer E, Dossou J, Violot D, Deutsch E, Bourhis J, Stoppa-Lyonnet D, Ribrag V, Carde P, Parmentier C, Berheim A, Turhan AG: Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma. Oncogene 2003, 22: 7905-7912. 10.1038\/sj.onc.1206826","journal-title":"Oncogene"},{"key":"35_CR27","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1182\/blood.V94.9.3262","volume":"94","author":"S Stilgenbauer","year":"1999","unstructured":"Stilgenbauer S, Winkler D, Ott G, Schaffner C, Leupolt E, Bentz M, Moller P, Muller-Hermelink HK, James MR, Lichter P, Dohner H: Molecular characterization of 11q deletions points to a pathogenetic role of ATM gene in mantle cell lymphoma. Blood 1999, 94: 3262-3264.","journal-title":"Blood"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-1-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-1-35\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-1-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T04:36:34Z","timestamp":1587184594000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-1-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,6]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-1-35","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,6]]},"article-number":"35"}}